Imaging the genetics of executive function

Biological Psychology

Volumn 79, Issue 1, 2008, Pages 30-42

  Greene, Ciara M ^a   Braet, Wouter ^a   Johnson, Katherine A ^a   Bellgrove, Mark A ^b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Dopamine; Executive functions; Genetics; Neuroimaging

Indexed keywords

ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; AUTISM; DISEASE MARKER; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ANALYSIS; HUMAN; NEUROIMAGING; PHENOTYPE; PRIORITY JOURNAL; SCHIZOPHRENIA; STIMULUS RESPONSE; SYMPTOMATOLOGY; WORKING MEMORY;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; BRAIN; COGNITION; HUMANS; INHIBITION (PSYCHOLOGY); MAGNETIC RESONANCE IMAGING; MEMORY; MENTAL DISORDERS; MOLECULAR BIOLOGY; PHENOTYPE; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 47949088834     PISSN: 03010511     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsycho.2007.11.009     Document Type: Article

References (178)

1. Adams J., Crosbie J., Wigg K., Ickowicz A., Pathare T., Roberts W., et al. Glutamate receptor, ionotropic, N-methyl d-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit/hyperactivity disorder in the 16p13 region. Molecular Psychiatry 9 5 (2004) 494-499
2. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders IV. American Psychiatric Association, Washington, DC.
3. Ando J., Ono Y., and Wright M.J. Genetic structure of spatial and verbal working memory. Behavioral Genetics 31 6 (2001) 615-624
4. Aron A.R., Fletcher P.C., Bullmore E.T., Sahakian B.J., and Robbins T.W. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nature Neuroscience 6 2 (2003) 115-116
5. Aron R.A., and Poldrack R.A. The cognitive neuroscience of response inhibition: Relevance for genetic research in attention-deficit/hyperactivity disorder. Biological Psychiatry 57 (2005) 1285-1292
6. Auerbach J.G., Benjamin J., Faroy M., Geller V., and Ebstein R. DRD4 related to infant attention and information processing: a developmental link to ADHD?. Psychiatric Genetics 11 1 (2001) 31-35
7. Badcock J.C., Michie P.T., Johnson L., and Combrinck J. Acts of control in schizophrenia: dissociating the components of inhibition. Psychological Medicine 32 2 (2002) 287-297
8. Baddeley A. Working Memory. Science 255 (1992) 556-559
9. Bailey A., Lecoutteur A., Gottesman I., Bolton P., Simonoff E., Yuzda E., et al. Autism as a strongly genetic disorder-evidence from a British twin study. Psychological Medicine 25 1 (1995) 63-77
10. Barch D.M., and Csernansky J.G. Abnormal parietal cortex activation during working memory in schizophrenia: verbal phonological coding disturbances versus domain-general executive dysfunction. American Journal of Psychiatry 164 7 (2007) 1090-1098
11. Barkley R.A., Smith K.M., Fischer M., and Navia B. An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7 +, DBH TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children followed to adulthood. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 141 5 (2006) 487-498
12. Barnett R., Maruff P., Vance A., Luk E.S., Costin J., Wood C., et al. Abnormal executive function in attention deficit hyperactivity disorder: the effect of stimulant medication and age on spatial working memory. Psychological Medicine 31 (2001) 1107-1115
13. Barr C.L., Xu C., Kroft J., Feng Y., Wigg K., Zai G., et al. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention defict/hyperactivity disorder. Biological Psychiatry 49 (2001) 333-339
14. Bellgrove M.A., Domschke K., Hawi Z., Kirley A., Mullins C., Robertson I.H., et al. The methionine allele of the COMT polymorphism impairs prefrontal cognition in children and adolescents with ADHD, Experimental. Brain Research 163 3 (2005) 352-360
15. Bellgrove M.A., Hawi Z., Gill M., and Robertson I.H. The cognitive genetics of attention deficit hyperactivity disorder (ADHD): sustained attention as a candidate phenotype. Cortex 42 6 (2006) 838-845
16. Bellgrove M.A., Hawi Z., Kirley A., Gill M., and Robertson I.H. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype. Neuropsychologia 43 13 (2005) 1847-1857
17. Bellgrove M.A., Hawi Z., Lowe N., Kirley A., Robertson I.H., and Gill M. DRD4 gene variants and sustained attention in attention deficit hyperactivity disorder (ADHD): effects of associated alleles at the VNTR and -521 SNP. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 136 1 (2005) 81-86
18. Bellgrove M.A., Hester R., and Garavan H. The functional neuroanatomical correlates of response variability: evidence from a response inhibition task. Neuropsychologia 42 14 (2004) 1910-1916
19. Bellgrove M.A., Mattingley J.B., Hawi Z., Mullins C., Kirley A., Gill M., et al. Impaired temporal resolution of visual attention and dopamine beta hydroxylase genotype in attention-deficit/hyperactivity disorder. Biological Psychiatry 60 10 (2006) 1039-1045
20. Bertolino A., Blasi G., Latorre V., Rubino V., Rampino A., Sinibaldi L., et al. Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. Journal of Neuroscience 26 15 (2006) 3918-3922
21. Bertolino A., Caforio G., Blasi G., De Candia M., Latorre V., Petruzzella V., et al. Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. American Journal of Psychiatry 161 10 (2004) 1798-1805
22. Bertolino A., Caforio G., Petruzzella V., Latorre V., Rubino V., Dimalta S., et al. Prefrontal dysfunction in schizophrenia controlling for COMT Val158Met genotype and working memory performance. Psychiatry Research 147 2-3 (2006) 221-226
23. Blasi G., Mattay V.S., Bertolino A., Elvevag B., Callicott J.H., Das S., et al. Effect of catechol-O-methyltransferase val158met genotype on attentional control. Journal of Neuroscience 25 20 (2005) 5038-5045
24. Boomsma D.I. Genetic analysis of cognitive failures (CFQ): a study of Dutch adolescent twins and their parents. European Journal of Personality 12 5 (1998) 321-330
25. Bradley J.D., and Golden C.J. Biological contributions to the presentation and understanding of attention-deficit/hyperactivity disorder: a review. Clinical Psychology Review 21 6 (2001) 907-929
26. Bruder G.E., Keilp J.G., Xu H., Shikhman M., Schori E., Gorman J.M., et al. Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations. Biological Psychiatry 58 11 (2005) 901-907
27. Buitelaar, J.K., 2002. Epidemiology: what have we learned over the last decade? In: Sandberg, S. (Ed.), Hyperactivity and Attention-Deficit Disorders. Cambridge University Press, Cambridge, UK.
28. Burdick K.E., Hodgkinson C.A., Szeszko P.R., Lencz T., Ekholm J.M., Kane J.M., et al. DISC1 and neurocognitive function in schizophrenia. Neuroreport 16 12 (2005) 1399-1402
29. Caldu X., Vendrell P., Bartres-Faz D., Clemente I., Bargallo N., Jurado M.A., et al. Impact of the COMT Val(108/158) Met and DAT genotypes on prefrontal function in healthy subjects. Neuroimage (2007)
30. Callicott J.H., Bertolino A., Mattay V.S., Langheim F.J.P., Duyn J., Coppola R., et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cerebral Cortex 10 11 (2000) 1078-1092
31. Callicott J.H., Egan M.F., Mattay V.S., Bertolino A., Bone A.D., Verchinksi B., et al. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. American Journal of Psychiatry 160 4 (2003) 709-719
32. Callicott J.H., Straub R.E., Pezawas L., Egan M.F., Mattay V.S., Hariri A.R., et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proceedings of the National Academy of Science 102 24 (2005) 8627-8632
33. Canli T., Omura K., Haas B.W., Fallgatter A., Constable R.T., and Lesch K.P. Beyond affect: a role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task. Proceedings of the National Academy of Science 102 34 (2005) 12224-12229
34. Capuano B., Crosby I.T., and Lloyd E.J. Schizophrenia: genesis, receptorology and current therapeutics. Current Medicinal Chemistry 9 5 (2002) 521-548
35. 2O PET study during single-trial stroop task performance. American Journal of Psychiatry 154 12 (1997) 1670-1675
36. Chamberlain S.R., Muller U., Blackwell A.D., Robbins T.W., and Sahakian B.J. Noradrenergic modulation of working memory and emotional memory in humans. Psychopharmacology (Berlin) 188 4 (2006) 397-407
37. Chambers C.D., Bellgrove M.A., Stokes M.G., Henderson T.R., Garavan H., Robertson I.H., et al. Executive "brake failure" following deactivation of human frontal lobe. Journal of Cognitive Neuroscience 18 3 (2006) 444-455
38. Chua S.E., and McKenna P.J. Schizophrenia-a brain disease? A critical review of structural and functional cerebral abnormality in the disorder. British Journal of Psychiatry 166 5 (1995) 563-582
39. Clark L., Roiser J.P., Cools R., Rubinsztein D.C., Sahakian B.J., and Robbins T.W. Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology (Berlin) 182 4 (2005) 570-578
40. Congdon E., Lesch K.P., and Canli T. Analysis of DRD4 and DAT polymorphisms and behavioral inhibition in healthy adults: Implications for impulsivity. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147B 1 (2007) 27-32
41. Corbetta M., and Shulman G.L. Control of goal-directed and stimulus-driven attention in the brain. Nature Reviews. Neuroscience 3 3 (2002) 201-215
42. Cornblatt B., Obuchowski M., Roberts S., Pollack S., and Erlenmeyer-Kimling L. Cognitive and behavioral precursors of schizophrenia. Developmental Psychopathology 11 3 (1999) 487-508
43. Cornish K.M., Manly T., Savage R., Swanson J., Morisano D., Butler N., et al. Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample. Molecular Psychiatry 10 7 (2005) 686-698
44. Crawford T.J., Haeger B., Kennard C., Reveley M.A., and Henderson L. Saccadic abnormalities in psychotic patients. I. Neuroleptic-free psychotic patients. Psychological Medicine 25 3 (1995) 461-471
45. Cubells J.F., van Kammen D.P., Kelley M.E., Anderson G.M., O'Connor D.T., Price L.H., et al. Dopamine ß-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Human Genetics 102 (1998) 533-540
46. Dempster, F.N., Brainerd, C.J., 1995. Interference and Inhibition in Cognition. Academic, San Diego.
47. Diamond A., Briand L., Fossella J.A., and Gehlbach L. Genetic and neurochemical modulation of prefrontal cognitive functions in children. American Journal of Psychiatry 161 1 (2004) 125-132
48. Donohoe G., Morris D.W., Clarke S., McGhee K.A., Schwaiger S., Nangle J.M., et al. Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study. Neuropsychologia 45 2 (2007) 454-458
49. Donohoe G., Reilly R., Clarke S., Meredith S., Greene B., Morris D., et al. Do antisaccade deficits in schizophrenia provide evidence of a specific inhibitory function?. Journal of the International Neuropsychological Society 12 6 (2006) 901-906
50. Dorval K.M., Wigg K.G., Crosbie J., Tannock R., Kennedy J.L., Ickowicz A., et al. Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder. Genes Brain and Behavior 6 5 (2007) 444-452
51. Durston S., Hulshoff Pol H.E., Schnack H.G., Buitelaar J.K., Steenhuis M.P., Minderaa R.B., et al. Magnetic resonance imaging of boys with attention-deficit/hyperactivity disorder and their unaffected siblings. Journal of the American Academy of Child and Adolescent Psychiatry 43 3 (2004) 332-340
52. Egan M.F., Goldberg T.E., Gscheidle T., Weirich M., Rawlings R., Hyde T.M., et al. Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biological Psychiatry 50 2 (2001) 98-107
53. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., et al. Effect of COMT Val 108/158 Met Genotype on Frontal Lobe Function and Risk for Schizophrenia. Proceedings of the National Academy of Science 98 (2001) 6917-6922
54. Egeland J., Rund B.R., Sundet K., Landro N.I., Asbjornsen A., Lund A., et al. Attention profile in schizophrenia compared with depression: differential effects of processing speed, selective attention and vigilance. Acta Psychiatria Scandinavia 108 4 (2003) 276-284
55. Ehlis A.C., Reif A., Herrmann M.J., Lesch K.P., and Fallgatter A.J. Impact of catechol-O-methyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders. Neuropsychopharmacology 32 1 (2007) 162-170
56. Fallgatter A.J., Jatzke S., Bartsch A.J., Hamelbeck B., and Lesch K.P. Serotonin transporter promoter polymorphism influences topography of inhibitory motor control. The International Journal of Neuropsychopharmacology 2 2 (1999) 115-120
57. Fan J., Fossella J.A., Sommer T., Wu Y., and Posner M.I. Mapping the genetic variation of executive attention onto brain activity. Proceedings of the National Academy of Science 100 12 (2003) 7406-7411
58. Faraone S.V., Biederman J., Lehman B.K., Keenan K., Norman D., Seidman L.J., et al. Evidence for the independent familial transmission of attention deficit hyperactivity disorder and learning disabilities: results from a family genetic study. American Journal of Psychiatry 150 6 (1993) 891-895
59. Fassbender C., Murphy K., Foxe J.J., Wylie G.R., Javitt D.C., Robertson I.H., et al. A topography of executive functions and their interactions revealed by functional magnetic resonance imaging. Cognitive Brain Research 20 (2004) 132-143
60. Fassbender C., and Schweitzer J.B. Is there evidence for neural compensation in attention deficit hyperactivity disorder? A review of the functional neuroimaging literature. Clinical Psychology Review 26 4 (2006) 445-465
61. Fossella J.A., Sommer T., Fan J., Wu Y., Swanson J.M., Pfaff D.W., et al. Assessing the molecular genetics of attention networks. BMC Neuroscience 3 (2002) 14
62. Frank M.J., Santamaria A., O'Reilly R.C., and Willcutt E. Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder. Neuropsychopharmacology 32 (2007) 1583-1599
63. Fukushima J., Fukushima K., Chiba T., Tanaka S., Yamashita I., and Kato M. Disturbances of voluntary control of saccadic eye movements in schizophrenic patients. Biological Psychiatry 23 7 (1988) 670-677
64. Garavan H., Ross T.J., and Stein E.A. Right hemispheric dominance of inhibitory control: an event-related functional MRI study. Proceedings of the National Academy of Science 96 14 (1999) 8301-8306
65. Gill M., Daly G., Heron S., Hawi Z., and Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Molecular Psychiatry 2 (1997) 311-313
66. Goldberg M.C., Mostofsky S.H., Cutting L.E., Mahone E.M., Astor B.C., Denckla M.B., et al. Subtle executive impairment in children with Autism and children with ADHD. Journal of Autism and Developmental Disorders 35 3 (2005) 279-293
67. Goldberg T.E., Egan M.F., Gscheidle, Cappola R., Weickert T., Kolachana B.S., et al. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Archives of General Psychiatry 60 (2003) 889-896
68. Goldberg T.E., and Weinberger D.R. Genes and the parsing of cognitive processes. Trends in Cognitive Science 8 7 (2004) 325-335
69. Goldman-Rakic, P.S., 1991. Prefrontal cortical dysfunction in schizophrenia: the relevance of working memory. In: Carroll, B. (Ed.), Psychopathology and the Brain. Raven Press, New York, pp. 1-23.
70. Gottesman I.I., and Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry 160 4 (2003) 636-645
71. Grahame-Smith D.G. Tryptophan hydroxylation in brain. Biochemical and Biophysical Research Communications 16 6 (1964) 586-592
72. Groot A.S., de Sonneville L.M., Stins J.F., and Boomsma D.I. Familial influences on sustained attention and inhibition in preschoolers. Journal of Child Psychology and Psychiatry 45 2 (2004) 306-314
73. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 297 5580 (2002) 400-403
74. Harris J.G., Kongs S., Allensworth D., Martin L., Tregellas J., Sullivan B., et al. Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacology 29 7 (2004) 1378-1385
75. Heaton R.K., Gladsjo J.A., Palmer B.W., Kuck J., Marcotte T.D., and Jeste D.V. Stability and course of neuropsychological deficits in schizophrenia. Archives of General Psychiatry 58 1 (2001) 24-32
76. Heinrichs R.W., and Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12 3 (1998) 426-445
77. Heinz A., and Smolka M.N. The effects of catechol O-methyltransferase genotype on brain activation elicited by affective stimuli and cognitive tasks. Reviews in the Neurosciences 17 3 (2006) 359-367
78. Heiser P., Heinzel-Gutenbrunner M., Frey J., Smidt J., Grabarkiewicz J., Friedel S., et al. Twin study on heritability of activity, attention, and impulsivity as assessed by objective measures. Journal of Attention Disorders 9 4 (2006) 575-581
79. Hershey T., Black K.J., Hartlein J., Braver T.S., Barch D.M., Carl J.L., et al. Dopaminergic modulation of response inhibition: an fMRI study Brain Research. Cognitive Brain Research 20 3 (2004) 438-448
80. Ho B.C., Wassink T.H., O'Leary D.S., Sheffield V.C., and Andreasen N.C. Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Molecular Psychiatry 10-13 229 (2005) 287-298
81. Hughes C., and Russell J. Autistic children's difficulty with mental disengagement from an object: it's implications for theories of autism. Developmental Psychology 29 (1993) 298-510
82. Johnson K.A., Kelly S.P., Bellgrove M.A., Barry E., Cox M., Gill M., et al. Response variability in attention deficit hyperactivity disorder: evidence for neuropsychological heterogeneity. Neuropsychologia 45 4 (2007) 630-638
83. Johnson K.A., Kelly S.P., Bellgrove M.A., Barry E., Cox M., Gill M., et al. Response variability in attention deficit hyperactivity disorder: evidence for neuropsychological heterogeneity. Neuropsychologia 45 (2007) 630-638
84. Johnson K.A., Robertson I.H., Kelly S.P., Silk T.J., Barry E., Dáibhis A., et al. Dissociation in performance of children with ADHD and high-functioning autism on a task of sustained attention. Neuropsychologia 45 10 (2007) 2234-2245
85. Jones P., and Cannon M. The new epidemiology of schizophrenia. The Psychiatric Clinics of North America 21 1 (1998) 1-25
86. Kana R.K., Keller T.A., Minshew N.J., and Just M.A. Inhibitory control in high-functioning autism: decreased activation and underconnectivity in inhibition networks. Biological Psychiatry 62 3 (2007) 198-206
87. Kiehl K.A., and Liddle P.F. An event-related functional magnetic resonance imaging study of an auditory oddball task in schizophrenia. Schizophrenia Research 48 2-3 (2001) 159-171
88. Kieling C., Roman T., Doyle A.E., Hutz M.H., and Rohde L.A. Association between DRD4 gene and performance of children with ADHD in a test of sustained attention. Biological Psychiatry 60 10 (2006) 1163-1165
89. Kinomura S., Larsson J., Gulyas B., and Roland P.E. Activation by attention of the human reticular formation and thalamic intralaminar nuclei. Science 271 5248 (1996) 512-515
90. Koczat D.L., Rogers S.J., Pennington B.F., and Ross R.G. Eye movement abnormality suggestive of a spatial working memory deficit is present in parents of autistic probands. Journal of Autism and Developmental 32 6 (2002) 513-518
91. Koshino H., Carpenter P.A., Minshew N.J., Cherkassky V.L., Keller T.A., and Just M.A. Functional connectivity in an fMRI working memory task in high-functioning autism. NeuroImage 24 (2005) 810-821
92. Koshino, H., Kana, R.K., Keller, T.A., Cherkassky, V.L., Minshew, N.J., Just, M.A., 2007. fMRI investigation of working memory for faces in autism: visual coding and underconnectivity with frontal areas. Cerebral Cortex, [Epub ahead of print].
93. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., and Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6 (1996) 243-250
94. Langley K., Marshall L., van den Bree M., Thomas H., Owen M., O'Donovan M., et al. Association of dopamine D4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD. American Journal of Psychiatry 161 (2004) 133-138
95. Lawrence N.S., Ross T.J., Hoffmann R., Garavan H., and Stein E.A. Multiple neuronal networks mediate sustained attention. Journal of Cognitive Neuroscience 15 7 (2003) 1028-1038
96. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 5292 (1996) 1527-1531
97. Levy F. What do dopamine transporter and catechol-o-methyltransferase tell us about attention deficit-hyperactivity disorder? Pharmacogenomic implications. The Australian and New Zealand Journal of Psychiatry 41 1 (2007) 10-16
98. Levy F., and Swanson J.M. Timing, space and ADHD: the dopamine theory revisited. The Australian and New Zealand Journal of Psychiatry 35 4 (2001) 504-511
99. Liu Y.-L., Fann C.S.-J., Liu C.-M., Chen W.J., Wu J.-Y., Hung S.-I., et al. A single nucleotide polymorphism fine mapping study of chromosome 1q42.1 reveals the vulnerability genes for schizophrenia, GNPAT and DISC1: association with impairment of sustained attention. Biological Psychiatry 60 6 (2006) 554-562
100. Lucki I. The spectrum of behaviors influenced by serotonin. Biological Psychiatry 44 3 (1998) 151-162
101. Luna B., Doll S.K., Hegedus S.J., Minshew N.J., and Sweeney J.A. Maturation of executive function in autism. Biological Psychiatry 61 4 (2007) 474-481
102. Luna B., Minshew N.J., Garver K.E., Lazar N.A., Thulborn K.R., Eddy W.F., et al. Neocortical system abnormalities in autism: an fMRI study of spatial working memory. Neurology 59 6 (2002) 834-840
103. Lungu O.V., Liu T., Waechter T., Willingham D.T., and Ashe J. Strategic modulation of cognitive control. Journal of Cognitive Neuroscience 19 8 (2007) 1302-1315
104. Manoach D.S., Press D.Z., Thangaraj V., Searl M.M., Goff D.C., Halpern E., et al. Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biological Psychiatry 45 9 (1999) 1128-1137
105. Martinussen R., Hayden J., Hogg-Johnson S., and Tannock R. A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 44 4 (2005) 377-384
106. Mattay V.S., Goldberg T.E., Fera F., Hariri A.R., Tessitore A., Egan M.F., et al. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proceedings of the National Academy of Science 100 10 (2003) 6186-6191
107. McCarthy G., Blamire A.M., Puce A., Nobre A.C., Bloch G., Hyder F., et al. Functional magnetic resonance imaging of human prefrontal cortex activation during a spatial working memory task. Proceedings of the National Academy of Science 91 18 (1994) 8690-8694
108. Mehta M.A., Swainson R., Ogilvie A.D., Sahakian J., and Robbins T.W. Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers. Psychopharmacology (Berlin) 159 1 (2001) 10-20
109. Mendrek A., Kiehl K.A., Smith A.M., Irwin D., Forster B.B., and Liddle P.F. Dysfunction of a distributed neural circuitry in schizophrenia patients during a working-memory performance. Psychological Medicine 35 2 (2005) 187-196
110. Menon V., Adleman N.E., White C.D., Glover G.H., and Reiss A.L. Error-related brain activation during a Go/NoGo response inhibition task. Human Brain Mapping 12 3 (2001) 131-143
111. Mink J.W. Neurobiology of basal ganglia circuits in Tourette syndrome: faulty inhibition of unwanted motor patterns?. Advances in Neurology 85 (2001) 113-122
112. Muller U., von Cramon D.Y., and Pollmann S. D1- versus D2-receptor modulation of visuospatial working memory in humans. Journal of Neuroscience 18 7 (1998) 2720-2728
113. National Institute of Mental Health's Genetics and Workgroup. Genetics and mental disorders. National Institute of Mental Health's Genetics Workgroup. Biological Psychiatry 45 5 (1999) 559-573
114. Nigg J.T. Neuropsychologic theory and findings in attention-deficit/hyperactivity disorder: the state of the field and salient challenges for the coming decade. Biological Psychiatry 57 11 (2005) 1424-1435
115. Ozonoff S., and Jensen J. Brief report: specific executive function profiles in three neurodevelopmental disorders. Journal of Autism and Developmental Disorders 29 2 (1999) 171-177
116. Ozonoff S., and McEvoy R.E. A longitudinal study of executive function and theory of mind development in autism. Developmental Psychopathology 6 (1994) 415-431
117. Ozonoff S., and Strayer D.L. Inhibitory function in nonretarded children with autism. Journal of Autism and Developmental Disorders 27 1 (1997) 59-77
118. Parasuraman R., Greenwood P.M., Kumar R., and Fossella J.A. Beyond heritability: neurotransmitter genes differentially modulate visuospatial attention and working memory. Psychological Science 16 3 (2005) 200
119. Passamonti L., Fera F., Magariello A., Cerasa A., Gioia M.C., Muglia M., et al. Monoamine oxidase-a genetic variations influence brain activity associated with inhibitory control: new insight into the neural correlates of impulsivity. Biological Psychiatry 59 4 (2006) 334-340
120. Paus T., and Zatorre R.J. Time-related changes in neural systems underlying attention and arousal during the performance of an auditory vigilance task. Journal of Cognitive Neuroscience 9 3 (1997) 392
121. Petrides M. Frontal lobes and behaviour. Current Opinion in Neurobiology 4 2 (1994) 207-211
122. Pietrzak R.H., Mollica C.M., Maruff P., and Snyder P.J. Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. Neuroscience and Biobehavioural Reviews 30 (2006) 1225-1245
123. Posner M.I., and Peterson S.E. The attention system of the human brain. Annual Review of Neuroscience 13 (1990) 35-42
124. Reuter M., Ott U., Vaitl D., and Hennig J. Impaired executive control is associated with a variation in the promoter region of the tryptophan hydroxylase 2 gene. Journal of Cognitive Neuroscience 19 3 (2007) 401-408
125. Rinehart N.J., Bradshaw J.L., Moss S.A., Brereton A.V., and Tonge B.J. Pseudo-random number generation in children with high-functioning autism and Asperger's disorder: further evidence for a dissociation in executive functioning?. Autism 10 1 (2006) 70-85
126. Risch N., and Rao D.C. Genetic linkage and complex diseases, with special reference to psychiatric disorders. Genetic Epidemiology 7 1 (1990) 3-16
127. Robertson I.H., Manly T., Andrade J., Baddeley B.T., and Yiend J. 'Oops!': Performance correlates of everyday attentional failures in traumatic brain injured and normal subjects. Neuropsychologia 35 6 (1997) 747-758
128. Roesch-Ely D., Scheffel H., Weiland S., Schwaninger M., Hundemer H.P., Kolter T., et al. Differential dopaminergic modulation of executive control in healthy subjects. Psychopharmacology (Berlin) 178 4 (2005) 420-430
129. Rommelse N.N., Altink M.E., de Sonneville L.M., Buschgens C.J., Buitelaar J., Oosterlaan J., et al. Are motor inhibition and cognitive flexibility dead ends in ADHD?. J Abnorm Child Psychol 35 6 (2007) 957-967
130. Ronald A., Happe F., Price T.S., Baron-Cohen S., and Plomin R. Phenotypic and genetic overlap between autistic traits at the extremes of the general population. Journal of the American Academy of Child and Adolescent Psychiatry 45 10 (2006) 1206-1214
131. Rubia K., Russell T., Bullmore E.T., Soni W., Brammer M.J., Simmons A., et al. An fMRI study of reduced left prefrontal activation in schizophrenia during normal inhibitory function. Schizophrenia Research 52 1-2 (2001) 47-55
132. Russo N., Flanagan T., Iarocci G., Berringer D., Zelazo P.D., and Burack J.A. Deconstructing executive deficits among persons with autism: implications for cognitive neuroscience. Brain and Cognition 65 1 (2007) 77-86
133. Rybakowski J.K., Borkowska A., Czerski P.M., Dmitrzak-Weglarz M., Skibinska M., Kapelski P., et al. Performance on the Wisconsin Card Sorting Test in schizophrenia and genes of dopaminergic inactivation (COMT, DAT, NET). Psychiatry Research 143 1 (2006) 13-19
134. Rybakowski J.K., Borkowska A., Czerski P.M., Kapelski P., Dmitrzak-Weglarz M., and Hauser J. An association study of dopamine receptors polymorphisms and the Wisconsin Card Sorting Test in schizophrenia. Journal of Neural Transmission 112 11 (2005) 1575-1582
135. Sanders, J., Johnson, K.A., Garavan, H., Gill, M., Gallagher, L., 2007. A review of neuropsychological and neuroimaging research in autistic spectrum disorders: Attention, inhibition and cognitive flexibility. Research in Autism Spectrum Disorders, [Epub ahead of print].
136. Schmidt L.A., Fox N.A., Perez-Edgar K., Hu S., and Hamer D.H. Association of DRD4 with attention problems in normal childhood development. Psychiatric Genetics 11 1 (2001) 25-29
137. Schmitz N., Daly E., and Murphy D. Frontal anatomy and reaction time in Autism. Neuroscience Letters 412 (2007) 12-17
138. Schmitz N., Rubia K., Daly E., Smith A., Williams S., and Murphy D.G. Neural correlates of executive function in autistic spectrum disorders. Biological Psychiatry 59 (2006) 7-16
139. Schneider F., Habel U., Reske M., Kellermann T., Stocker T., Shah N.J., et al. Neural correlates of working memory dysfunction in first-episode schizophrenia patients: an fMRI multi-center study. Schizophrenia Research 89 1-3 (2007) 198-210
140. Sesack S.R., Hawrylack V.A., Matus C., Guido M.A., and Levey A.I. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. Journal of Neuroscience 18 (1998) 2697-2708
141. Silk T., Vance A., Rinehart N., Egan G., O'Boyle M., Bradshaw J.L., et al. Fronto-parietal activation in attention-deficit hyperactivity disorder, combined type: functional magnetic resonance imaging study. British Journal of Psychiatry 187 (2005) 282-283
142. Silk T.J., Rinehart N.J., Bradshaw J.L., Tonge L.F.L., Egan G.F., O'Boyle M.W., et al. Visuospatial processing and the function of prefrontal-parietal networks in autism spectrum disorder: a functional MRI study. American Journal of Psychiatry 163 8 (2006) 1440-1443
143. Slaats-Willemse D., Swaab-Barneveld H., de Sonneville L., van der Meulen E., and Buitelaar J. Deficient response inhibition as a cognitive endophenotype of ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 42 10 (2003) 1242-1248
144. Smyrnis N., Avramopoulos D., Evdokimidis I., Stefanis C.N., Tsekou H., and Stefanis N.C. Effect of schizotypy on cognitive performance and its tuning by COMT val158 met genotype variations in a large population of young men. Biological Psychiatry 61 7 (2007) 845-853
145. Stefanis N.C., Os J.V., Avramopoulos D., Smyrnis N., Evdokimidis I., Hantoumi I., et al. Variation in catechol-o-methyltransferase val158 met genotype associated with schizotypy but not cognition: a population study in 543 young men. Biological Psychiatry 56 7 (2004) 510-515
146. Stefanis N.C., Trikalinos T.A., Avramopoulos D., Smyrnis N., Evdokimidis I., Ntzani E.E., et al. Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biol Psychiatry 62 7 (2007) 784-792
147. Stins J.F., Tollenaar M.S., Slaats-Willemse D.I., Buitelaar J.K., Swaab-Barneveld H., Verhulst F.C., et al. Sustained attention and executive functioning performance in attention-deficit/hyperactivity disorder. Child Neuropsychology 11 3 (2005) 285-294
148. Stoltenberg S.F., Glass J.M., Chermack S.T., Flynn H.A., Li S., Weston M.E., et al. Possible association between response inhibition and a variant in the brain-expressed tryptophan hydroxylase-2 gene. Psychiatric Genetics 16 1 (2006) 35-38
149. Szekeres G., Keri S., Juhasz A., Rimanoczy A., Szendi I., Czimmer C., et al. Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 124 1 (2004) 1-5
150. Szöke A., Schürhoff F., Méary A., Mathieu F., Chevalier F., Trandafir A., et al. Lack of influence of COMT and NET genes variants on executive functions in schizophrenic and bipolar patients, their first-degree relatives and controls. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 141B 5 (2006) 504-512
151. Thapar A., Holmes J., Poulton K., and Harrington R. Genetic basis of attention deficit and hyperactivity. British Journal of Psychiatry 174 (1999) 105-111
152. Thermenos H.W., Goldstein J.M., Buka S.L., Poldrack R.A., Koch J.K., Tsuang M.T., et al. The effect of working memory performance on functional MRI in schizophrenia. Schizophrenia Research 74 2-3 (2005) 179-194
153. Thoma P., Wiebel B., and Daum I. Response inhibition and cognitive flexibility in schizophrenia with and without comorbid substance use disorder. Schizophrenia Research 92 1-3 (2007) 168-180
154. Todd R.D., Jong Y.J., Lobos E.A., Reich W., Heath A.C., and Neuman R.J. No association of the dopamine transporter gene 3' VNTR polymorphism with ADHD subtypes in a population sample of twins. American Journal of Medical Genetics 105 8 (2001) 745-748
155. Townsend J., Harris N.S., and Courchesne E. Visual attention abnormalities in autism: delayed orienting to location. Journal of the International Neuropsychological Society 2 6 (1996) 541-550
156. Ucok A., Alpsan H., Cakir S., and Saruhan-Direskeneli G. Association of a serotonin receptor 2A gene polymorphism with cognitive functions in patients with schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 144B 5 (2007) 704-707
157. Valera E.M., Faraone S.V., Biederman J., Poldrack R.A., and Seidman L.J. Functional neuroanatomy of working memory in adults with attention-deficit/hyperactivity disorder. Biological Psychiatry 57 5 (2005) 439-447
158. Vance A., Silk T.J., Casey M., Rinehart N.J., Bradshaw J.L., Bellgrove M.A., et al. Right parietal dysfunction in children with attention deficit hyperactivity disorder, combined type: a functional MRI study. Mol Psychiatry 12 9 (2007) 826-832
159. Verte S., Geurts H.M., Roeyers H., Oosterlaan J., and Sergeant J.A. Executive functioning in children with autism and Tourette syndrome. Developmental Psychopathology 17 2 (2005) 415-445
160. Vijayraghavan S., Wang M., Birnbaum S.G., Williams G.V., and Arnsten A.F. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nature Neuroscience 10 3 (2007) 376-384
161. Vink M., Ramsey N.F., Raemaekers M., and Kahn R.S. Striatal dysfunction in schizophrenia and unaffected relatives. Biological Psychiatry 60 1 (2006) 32-39
162. Voeller K.K. Attention-deficit hyperactivity disorder (ADHD). Journal of Child Neurology 19 10 (2004) 798-814
163. Wager T.D., and Smith E.E. Neuroimaging studies of working memory: a meta-analysis. Cognitive, Affective & Behavioral Neuroscience 3 4 (2003) 255-274
164. Walter H., Vasic N., Hose A., Spitzer M., and Wolf R.C. Working memory dysfunction in schizophrenia compared to healthy controls and patients with depression: Evidence from event-related fMRI. NeuroImage 35 4 (2007) 1551-1561
165. Wang K., Fan J., Dong Y., Wang C.-q., Lee T.M.C., and Posner M.I. Selective impairment of attentional networks of orienting and executive control in schizophrenia. Schizophrenia Research 78 2-3 (2005) 235-241
166. Wedenoja, J., Loukola, A., Tuulio-Henriksson, A., Paunio, T., Ekelund, J., Silander, K., et al. (2007). Replication of linkage on chromosome 7q22 and association of the regional Reelin gene with working memory in schizophrenia families. Molecular Psychiatry.
167. Weiss, G., Hechtman, L., 1993. Hyperactive Children Grown Up. Guilford Press, New York.
168. Weissman D.H., Roberts K.C., Visscher K.M., and Woldorff M.G. The neural bases of momentary lapses in attention. Nature Neuroscience 9 (2006) 971-978
169. Willcutt E.G., Doyle A.E., Nigg J.T., Faraone S.V., and Pennington B.F. Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biological Psychiatry 57 11 (2005) 1336-1346
170. Winterer G., Musso F., Konrad A., Vucurevic G., Stoeter P., Sander T., et al. Association of attentional network function with exon 5 variations of the CHRNA4 gene. Human Molecular Genetics 16 18 (2007) 2165-2174
171. Winterer G., Musso F., Vucurevic G., Stoeter P., Konrad A., Seker B., et al. COMT genotype predicts BOLD signal and noise characteristics in prefrontal circuits. Neuroimage 32 4 (2006) 1722-1732
172. Wodka E.L., Mahone E.M., Blankner J.G., Larson J.C., Fotedar S., Denckla M.B., et al. Evidence that response inhibition is a primary deficit in ADHD. Journal of Clinical and Experimental Neuropsychology 29 (2007) 345-356
173. Wright M., De Geus E., Ando J., Luciano M., Posthuma D., Ono Y., et al. Genetics of cognition: outline of a collaborative twin study. Twin Research 4 1 (2001) 48-56
174. Wykes T., Reeder C., and Corner J. The prevalence and stability of an executive processing deficit, response inhibition, in people with chronic schizophrenia. Schizophrenia Research 46 2-3 (2000) 241-253
175. Xu H., Kellendonk C.B., Simpson E.H., Keilp J.G., Bruder G.E., Polan H.J., et al. DRD2 C957T polymorphism interacts with the COMT Val158Met polymorphism in human working memory ability. Schizophrenia Research 90 1-3 (2007) 104-107
176. Yang M.S., and Gill M. A review of gene linkage, association and expression studies in autism and an assessment of convergent evidence. International Journal of Developmental Neuroscience 25 (2007) 69-85
177. Yu Y.W., Tsai S.J., Hong C.J., Chen M.C., Yang C.W., and Chen T.J. Association study of a functional MAOA-uVNTR gene polymorphism and cognitive function in healthy females. Neuropsychobiology 52 2 (2005) 77-82
178. Zabetian C.P., Buxbaum S.G., Elston R.C., Kohnke M.D., Anderson G.M., Gelernter J., et al. The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activity. American Journal of Human Genetics 72 6 (2003) 1389-1400